SOW
ALLO icon

State of Wyoming’s Allogene Therapeutics ALLO Stock Holding History

State of Wyoming’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.4K Buy
+33,840
New +$74.3K 0.01% 1579

Other funds holding ALLO

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

State of Wyoming's ALLO Position: Q2 2026 in Review

State of Wyoming opened a new position in Allogene Therapeutics (ALLO) in Q2 2026: 33,840 shares worth $70.4K. The stake represents 0.01% of the portfolio and ranks #1579 among its holdings.

57 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • State of Wyoming held 33,840 shares of Allogene Therapeutics worth $70.4K as of Q2 2026.
  • Allogene Therapeutics was a new State of Wyoming position in Q2 2026.
  • Allogene Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1579 holding.
  • 57 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.